tau protein

Tau proteins disrupt the movement of molecules into and out of neuronal cells’ nuclei.

A study explores how nuclear pore complexes are disrupted in Alzheimer’s disease.

Levels of tau, amyloid-β 42, and IL-10 extracted from extracellular vesicles that started out in the brain were higher in military personal suffering head injuries compared with healthy soldiers.

A proposed definition of the disease emphasizes signs of neurodegeneration and the presence of β-amyloid and tau, rather than cognitive symptoms.

The findings suggest that faster synthesis, rather than decreased clearance, causes the protein to build up in neurons.

Pressure from simulated blast waves, similar to those generated by explosives, induced molecular markers of stress and injury within mouse retinas.

A selection of notable quotes from the annual Society for Neuroscience meeting

Targeting tau antibodies does not require effector function, researchers report.

An enzyme that cleaves tau protein in acidic cellular conditions may trigger early events in Alzheimer’s disease.

Kerry Grens updates the latest science news for December 13, 2013

In living humans, researchers image snarls of tau, one of the proteins associated with Alzheimer's disease.

Biomarkers of Alzheimer’s disease are ready for widespread use in clinical trials.